These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18353972)

  • 1. Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis.
    Yan W; Bentley B; Shao R
    Mol Biol Cell; 2008 May; 19(5):2278-88. PubMed ID: 18353972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
    Raimondi C; Fantin A; Lampropoulou A; Denti L; Chikh A; Ruhrberg C
    J Exp Med; 2014 Jun; 211(6):1167-83. PubMed ID: 24863063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling.
    Frasca F; Pandini G; Malaguarnera R; Mandarino A; Messina RL; Sciacca L; Belfiore A; Vigneri R
    J Biol Chem; 2007 Sep; 282(36):26077-88. PubMed ID: 17620332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1.
    Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F
    Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation.
    Zheng J; Wen Y; Song Y; Wang K; Chen DB; Magness RR
    Biol Reprod; 2008 Jan; 78(1):143-50. PubMed ID: 17901071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.
    Stephens RS; Servinsky LE; Rentsendorj O; Kolb TM; Pfeifer A; Pearse DB
    Am J Physiol Cell Physiol; 2014 Mar; 306(6):C559-69. PubMed ID: 24401847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
    Wang S; Wilkes MC; Leof EB; Hirschberg R
    FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
    Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
    J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin-3F is an inhibitor of tumor angiogenesis.
    Kessler O; Shraga-Heled N; Lange T; Gutmann-Raviv N; Sabo E; Baruch L; Machluf M; Neufeld G
    Cancer Res; 2004 Feb; 64(3):1008-15. PubMed ID: 14871832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of imatinib (STI571).
    Buchdunger E; O'Reilly T; Wood J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S28-36. PubMed ID: 12528770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abl family kinases regulate endothelial barrier function in vitro and in mice.
    Chislock EM; Pendergast AM
    PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
    Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
    FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.
    Acevedo LM; Barillas S; Weis SM; Göthert JR; Cheresh DA
    Blood; 2008 Mar; 111(5):2674-80. PubMed ID: 18180379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.
    Hata Y; Rook SL; Aiello LP
    Diabetes; 1999 May; 48(5):1145-55. PubMed ID: 10331422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in an in vitro quantitative microcarrier-based three-dimensional fibrin angiogenesis system.
    Sun XT; Ding YT; Yan XG; Wu LY; Li Q; Cheng N; Qiu YD; Zhang MY
    World J Gastroenterol; 2004 Sep; 10(17):2524-8. PubMed ID: 15300897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells.
    Aoki S; Cho SH; Ono M; Kuwano T; Nakao S; Kuwano M; Nakagawa S; Gao JQ; Mayumi T; Shibuya M; Kobayashi M
    Anticancer Drugs; 2006 Mar; 17(3):269-78. PubMed ID: 16520655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
    Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
    J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.